The short-term therapeutic effect of recombinant human bone morphogenetic protein-2 on collagenase-induced lumbar facet joint osteoarthritis in rats 

Slides:



Advertisements
Similar presentations
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Advertisements

Chitosan–glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects  C.D.
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair  Y. Mifune, T. Matsumoto, K.
Angiogenic activity of subchondral bone during the progression of osteoarthritis in a rabbit anterior cruciate ligament transection model  M. Saito, T.
Osteoarthritis cartilage histopathology: grading and staging
B. Bai, Y. Li  Osteoarthritis and Cartilage 
Intra-articular injection of the cyclooxygenase-2 inhibitor parecoxib attenuates osteoarthritis progression in anterior cruciate ligament-transected knee.
The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior.
Implantation of bone marrow-derived buffy coat can supplement bone marrow stimulation for articular cartilage repair  L.H. Jin, B.H. Choi, Y.J. Kim, S.R.
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Nociceptive phenotype alterations of dorsal root ganglia neurons innervating the subchondral bone in osteoarthritic rat knee joints  K. Aso, M. Izumi,
Granulocyte macrophage – colony stimulating factor (GM-CSF) significantly enhances articular cartilage repair potential by microfracture  M.-D. Truong,
Alleviation of osteoarthritis by calycosin-7-O-β-d-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model  S.I. Choi,
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair  Y. Mifune, T. Matsumoto, K.
Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan.
M. Siebelt, A. E. van der Windt, H. C. Groen, M. Sandker, J. H
Effects of short-term gentle treadmill walking on subchondral bone in a rat model of instability-induced osteoarthritis  H. Iijima, T. Aoyama, A. Ito,
Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints  L. Christensen, L. Camitz, K.E. Illigen,
Nociceptive phenotype alterations of dorsal root ganglia neurons innervating the subchondral bone in osteoarthritic rat knee joints  K. Aso, M. Izumi,
Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte  T. Nakase, M.D., Ph.D., T. Miyaji, M.D., T. Tomita, M.D.,
The groove model of osteoarthritis applied to the ovine fetlock joint
Bone turnover and articular cartilage differences localized to subchondral cysts in knees with advanced osteoarthritis  Y. Chen, T. Wang, M. Guan, W.
Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes 
Cartilage degeneration in the goat knee caused by treating localized cartilage defects with metal implants  R.J.H. Custers, W.J.A. Dhert, D.B.F. Saris,
Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage  M. Rutgers, M.J.P. van Pelt, W.J.A. Dhert, L.B.
Chitosan–glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects  C.D.
L.N. Nwosu, P.I. Mapp, V. Chapman, D.A. Walsh 
An in vivo cross-linkable hyaluronan gel with inherent anti-inflammatory properties reduces OA cartilage destruction in female mice subjected to cruciate.
Study of subchondral bone adaptations in a rodent surgical model of OA using in vivo micro-computed tomography  D.D. McErlain, M.Sc., C.T.G. Appleton,
NEL-like molecule-1-modified bone marrow mesenchymal stem cells/poly lactic-co- glycolic acid composite improves repair of large osteochondral defects.
Effects of short-term gentle treadmill walking on subchondral bone in a rat model of instability-induced osteoarthritis  H. Iijima, T. Aoyama, A. Ito,
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the horse  C.W. McIlwraith, D.D. Frisbie, C.E.
Angiogenesis in two animal models of osteoarthritis
Cartilage damage pattern in relation to subchondral plate thickness in a collagenase- induced model of osteoarthritis  S.M. Botter, M.Sc., G.J.V.M. van.
The support of matrix accumulation and the promotion of sheep articular cartilage defects repair in vivo by chitosan hydrogels  T. Hao, N. Wen, J.-K.
Promotion of the intrinsic damage–repair response in articular cartilage by fibroblastic growth factor-2  F.M.D. Henson, Ph.D., E.A. Bowe, Ph.D., M.E.
PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage  S. Otsuka, M.D., T. Aoyama, M.D., Ph.D.,
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rabbit  S. Laverty, C.A. Girard, J.M. Williams,
Angiogenic activity of subchondral bone during the progression of osteoarthritis in a rabbit anterior cruciate ligament transection model  M. Saito, T.
Progranulin plays a chondroprotective role in a surgically-induced osteoarthritis in mice through TNFR2 pathway  J. Wei, Y. Zhao, C. Liu  Osteoarthritis.
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig  V.B. Kraus, J.L. Huebner, J. DeGroot,
A novel exogenous concentration-gradient collagen scaffold augments full-thickness articular cartilage repair  T. Mimura, M.D., S. Imai, M.D., M. Kubo,
Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human 
Intra-articular magnesium sulfate (MgSO4) reduces experimental osteoarthritis and nociception: association with attenuation of N-methyl-d-aspartate (NMDA)
Destabilization of the medial meniscus leads to subchondral bone defects and site- specific cartilage degeneration in an experimental rat model  H. Iijima,
The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone  K. Takebe, M.F. Rai, E.J. Schmidt,
The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain  L.
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis  P.I. Mapp, D.R. Sagar,
Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium.
A. Ludin, J.J. Sela, A. Schroeder, Y. Samuni, D.W. Nitzan, G. Amir 
Exercise intervention increases expression of bone morphogenetic proteins and prevents the progression of cartilage-subchondral bone lesions in a post-traumatic.
Osteoarthritis cartilage histopathology: grading and staging
The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study  G. Tardif, Ph.D., J.-P. Pelletier,
Quantitative MR T2 measurement of articular cartilage to assess the treatment effect of intra-articular hyaluronic acid injection on experimental osteoarthritis.
E.B. Hunziker, M.D., A. Stähli, D.M.D.  Osteoarthritis and Cartilage 
Joint instability leads to long-term alterations to knee synovium and osteoarthritis in a rabbit model  C. Egloff, D.A. Hart, C. Hewitt, P. Vavken, V.
Nanoindentation modulus of murine cartilage: a sensitive indicator of the initiation and progression of post-traumatic osteoarthritis  B. Doyran, W. Tong,
Significance of the serum CTX-II level in an osteoarthritis animal model: a 5-month longitudinal study  M.E. Duclos, O. Roualdes, R. Cararo, J.C. Rousseau,
Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage  F. Wei, J. Zhou, X. Wei,
K. Kuroki, C.R. Cook, J.L. Cook  Osteoarthritis and Cartilage 
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
Arjen B. Blom, Ph. D. , Peter L. E. M. van Lent, Ph. D. , Astrid E. M
Matrix-associated autologous chondrocyte transplantation in a compartmentalized early stage of osteoarthritis  M. Schinhan, M. Gruber, R. Dorotka, M.
Quantitative pre-clinical screening of therapeutics for joint diseases using contrast enhanced micro-computed tomography  N.J. Willett, T. Thote, M. Hart,
Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair  A.C. Kuo, M.D., Ph.D., J.J. Rodrigo, M.D.,
Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and.
Altered expression of chondroitin sulfate structure modifying sulfotransferases in the articular cartilage from adult osteoarthritis and Kashin-Beck disease 
K.L. Caldwell, J. Wang  Osteoarthritis and Cartilage 
B.D. Bomsta, M.S., L.C. Bridgewater, Ph.D., R.E. Seegmiller, Ph.D. 
Usefulness of specific OA biomarkers, thrombin-cleaved osteopontin, in the posterior cruciate ligament OA rabbit model  S.G. Gao, L. Cheng, C. Zeng, L.C.
Presentation transcript:

The short-term therapeutic effect of recombinant human bone morphogenetic protein-2 on collagenase-induced lumbar facet joint osteoarthritis in rats  T.-T. Yeh, M.D., S.-S. Wu, M.D., C.-H. Lee, M.D., Z.-H. Wen, Ph.D., H.-S. Lee, M.D., Ph.D., Z. Yang, M.D., M.E. Nimni, Ph.D., B. Han, Ph.D.  Osteoarthritis and Cartilage  Volume 15, Issue 12, Pages 1357-1366 (December 2007) DOI: 10.1016/j.joca.2007.04.019 Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Experimental protocol and representative section of collagenase-induced OA of the facet joint. (A) Experimental protocol. In the right-side facet joint, OA was induced by an intra-articular injection of 5U of collagenase type II. After 2 weeks, four groups were studied according to the different treatments. (B) Photograph of facet joint stained with Safranin O. The left-side facet joint was used as normal control. The right-side facet joint showed spontaneous healing without treatment at 3 weeks. IAP=inferior articular process of vertebra. SAP=superior articular process of vertebra. IVD=intervertebral disc. Bar=1mm. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Photographs of facet joint cartilage stained with Safranin O in the normal control group (A,B), collagenase-exposed joint (C–J), the untreated group (C,D), the saline-treated group (E,F), the rhBMP-2 10ng treated group (G,H), and the rhBMP-2 100ng treated group (I,J) at 3 and 6 weeks after treatment. In the normal control group (A,B), the articular surface was intact (black arrow). The cartilage matrix stained strongly with Safranin O. In the untreated group (C,D) and the saline-treated group (E,F), fissures extending into the middle and deep zones (long white arrow) and cartilage erosion (long black arrow) were observed. The cartilage matrix with loss of Safranin O staining was noted. Chondrocyte cloning (short white arrow) and hypocellularity of chondrocyte (short black arrow) were observed. Inter-trabecular fibrous tissue proliferation including young fibroblasts and new blood vessels, and focal new bone formation were observed (open arrow). In the rhBMP-2-treated groups (G–J), the severity of structure damage was decreased (arrow). Chondrocyte proliferation was observed. Most of the cartilage matrix was stained well with Safranin O. Focal changes in subchondral bone were observed (open arrow). Bar=500μm. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 Safranin O stained sections showed adverse side effects of high dosage rhBMP-2 treatment. (A) Normal control of facet joint. (B) Three weeks after rhBMP-2 100ng injection, overgrowth of cartilage (long white arrow) and severe proliferation of synovial fibroblast (short black arrow) caused an obliteration of joint space. Chondrophyte formation was observed (long black arrow). Multifocal fragmentation of bony trabeculae surrounded by osteoclast and fibrous tissue was noted (open arrow). Bone marrow elements were replaced by loosely arranged spindle cells in a fibrous stroma. Hypertrophy of the superior articular process of vertebra was noted (double black arrows). The representative photographs in A and B were obtained from the same section. (C) Six weeks after rhBMP-2 100ng injection, newly formed osteophyte (black arrow) was observed (A–C: bar=1mm). (D) A higher magnification of the rectangular outlines in C demonstrates the process of endochondral ossification. Bar=200μm. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 Histological scores for cartilage in facet joint for the normal control, the untreated group, the saline-treated group, the rhBMP-2 10ng treated group, and the rhBMP-2 100ng treated group at 3 and 6 weeks post-treatment. The values presented are the means and standard deviation for six animals. (A) Shown are values of the modified Mankin scores with comparisons between groups. (B) Shown are scores for the histologic parameters (structure, chondrocyte, and Safranin O staining) with comparisons between groups. † P<0.01, * P<0.05: significantly greater than the normal control group; # P<0.01, § P<0.05: significantly less than the untreated group; ¶ P<0.01, ‡ P<0.05: significantly less than the saline-treated group; Δ P<0.05: significantly less than the rhBMP-2 100ng treated group, by the Mann–Whitney U test. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 (A–J) Histological demonstration of synovium stained with H&E, the normal control group (A,B), collagenase-induced OA (C–J), the untreated group (C,D), the saline-treated group (E,F), the rhBMP-2 10ng treated group (G,H), and the rhBMP-2 100ng treated group (I,J) at 3 and 6 weeks after treatment. In the normal control (A,B), the synovium consists of a thin layer of synovial cells (black arrow) on top of a loose connective tissue subintimal layer (white arrow). In the collagenase-exposed joint (C–J), synovial reaction included hypertrophy or hyperplasia of synovial lining cells (long black arrow), proliferation of granulation tissue (long white arrow), and infiltration of inflammatory cells. Bar=100μm. (K) Synovium score with comparisons between groups at 3 and 6 weeks. # Significantly greater than the normal control group (P<0.01); § significantly greater than the untreated group (P<0.01); * significantly greater than the saline-treated group (P<0.01); ¶ significantly greater than the 10ng of rhBMP-2-treated group (P<0.05), by the Mann–Whitney U test. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 (A) Representative immunohistochemical stain score for collagen type II. Bar=100μm. (B) Collagen type II was analyzed based upon the staining intensity using an arbitrary score. The values presented are the means and standard deviation for six animals. ‡ Significantly reduced compared to the normal control group; § significantly reduced compared to the rhBMP-2 10ng treated group; * significantly reduced compared to the rhBMP-2 100ng treated group (all P<0.01), by the Mann–Whitney U test. Osteoarthritis and Cartilage 2007 15, 1357-1366DOI: (10.1016/j.joca.2007.04.019) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions